Summary
Machine-generated summaryThe Ministry of Defence, U.M 02175 Constanta ('Dr Alexandru Gafencu' Emergency Military Hospital Constanta), awarded a framework agreement for oncology medicines in 12 lots, covering products such as Sacituzumab Govitecan, Avelumab, Pembrolizumab, Trastuzumab Emtansine, Cemiplimab, Bevacizumab and Ramucirumab. Winners: FARMEXIM S.A., ALLIANCE HEALTHCARE ROMANIA SRL, DR.MAX, S.C. DONA.LOGISTICA S.R.L. and BIO EEL S.R.L. Estimated value: EUR 2,678,893.76. Framework agreements enter into force on 18.10.2026 or when quantities are exhausted, running until 17.10.2026; for lot 5, Cemiplimab, they take effect on award.
Description
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 3 days ago
More from this buyer
Full buyer profile5 open tenders right now
- Procurement of medical supplies for the Emergency Department 1 day left
- Current repair and maintenance works on the facade of Pavilion SM2 2 days left
- Reagents needed for the operation of the bacteriology - immunology department of the medical analysis laboratory - 3 lots 9 days left
Recent awards
Similar tenders
1
day left
€169,005
est. value
1
day left
€616,850
est. value
1
day left
€172,767,852
est. value
1
day left
€2,071,619
est. value
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €10,101,350
- Buyer track record on Aperlena
- 77 notices tracked · 40 awarded
- €1,929,196 in awarded contracts
Never miss a tender like this
320 new notices in Medical equipment & pharmaceuticals in Romania in the last 7 days. Get an email when new ones appear. Free.
Set up my alert